Steven Favaloro, incoming Genezen CEO (L) and Mark Womack, incoming BioCina CEO

Con­tract man­u­fac­tur­ers BioCi­na and Genezen name new CEOs

A pair of CD­MOs are bring­ing in new CEOs.

Tak­ing the helm at BioCi­na is Mark Wom­ack. Ac­cord­ing to his LinkedIn pro­file, Wom­ack has been in lead­er­ship po­si­tions at sev­er­al con­tract man­u­fac­tur­ers. His ca­reer spans more than 30 years, in­clud­ing roles such as CEO of the con­tract man­u­fac­tur­er KBI Bio­phar­ma and Se­lex­is SA. Be­fore that, he was CEO of Stelis Bio­phar­ma and chief busi­ness of­fi­cer of Seat­tle-based man­u­fac­tur­er AGC Bi­o­log­ics.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.